Record Revenue Growth
Revenue reached $8.7 million in Q3 2025, up 33% year-over-year and 18% sequentially, with strong gross margins of 86%.
Successful Integration of NeuroMetrix Acquisition
Quell Fibromyalgia product exceeded revenue expectations and was integrated into the VA hospital channel ahead of schedule.
Expansion in VA Hospital System
The number of VA hospital facilities purchasing gammaCore products increased from 166 to 195 over the past year.
Growth in Health and Wellness Products
Health and wellness product revenue reached $1.9 million, a 54% sequential increase and 121% year-on-year, driven by the Truvaga platform.
Strategic Investment in AI and Software
Partnership with StratejAI to develop AI-driven applications for wellness products, aiming for new recurring revenue streams.